InSite Vision has again secured the development rights for zithromycin ophthalmic solution 2%, trademarked as AzaSite Xtra, from Merck's subsidiary, Inspire Pharmaceuticals, in North America. According to the deal, a joint development ...
Tags: North America, InSite Vision, AzaSite Xtra